Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1003132.RAcypSP-baQXT2HvDdC3eVM1v6tTu5Mw_Zt1aU9tSj_qQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1003132.RAcypSP-baQXT2HvDdC3eVM1v6tTu5Mw_Zt1aU9tSj_qQ130_assertion type Assertion NP1003132.RAcypSP-baQXT2HvDdC3eVM1v6tTu5Mw_Zt1aU9tSj_qQ130_head.
- NP1003132.RAcypSP-baQXT2HvDdC3eVM1v6tTu5Mw_Zt1aU9tSj_qQ130_assertion description "[mSOD1 microglia isolated from ALS mice at disease onset expressed higher levels of Ym1, CD163 and BDNF (markers of M2) mRNA and lower levels of Nox2 (a marker of M1) mRNA compared with mSOD1 microglia isolated from ALS mice at end-stage disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1003132.RAcypSP-baQXT2HvDdC3eVM1v6tTu5Mw_Zt1aU9tSj_qQ130_provenance.
- NP1003132.RAcypSP-baQXT2HvDdC3eVM1v6tTu5Mw_Zt1aU9tSj_qQ130_assertion evidence source_evidence_literature NP1003132.RAcypSP-baQXT2HvDdC3eVM1v6tTu5Mw_Zt1aU9tSj_qQ130_provenance.
- NP1003132.RAcypSP-baQXT2HvDdC3eVM1v6tTu5Mw_Zt1aU9tSj_qQ130_assertion SIO_000772 22735487 NP1003132.RAcypSP-baQXT2HvDdC3eVM1v6tTu5Mw_Zt1aU9tSj_qQ130_provenance.
- NP1003132.RAcypSP-baQXT2HvDdC3eVM1v6tTu5Mw_Zt1aU9tSj_qQ130_assertion wasDerivedFrom befree-20150227 NP1003132.RAcypSP-baQXT2HvDdC3eVM1v6tTu5Mw_Zt1aU9tSj_qQ130_provenance.
- NP1003132.RAcypSP-baQXT2HvDdC3eVM1v6tTu5Mw_Zt1aU9tSj_qQ130_assertion wasGeneratedBy ECO_0000203 NP1003132.RAcypSP-baQXT2HvDdC3eVM1v6tTu5Mw_Zt1aU9tSj_qQ130_provenance.